Burning Rock Biotech Ltd. ADR

Burning Rock Biotech Ltd. ADR is a China-based cancer diagnostics company focused on next-generation sequencing solutions for precision oncology. The company develops and commercializes cancer therapy selection tests designed to help physicians identify genetic alterations and match patients with targeted treatment options. Its business also includes cancer early detection services and pharma research and development support, giving it a role across both clinical care and biopharmaceutical research. Burning Rock Biotech serves hospitals, laboratories, and pharmaceutical partners in China and the United States, with operations centered on molecular diagnostics and liquid biopsy applications. Through its testing platforms and oncology-focused laboratory services, the company contributes to the broader adoption of genomics in cancer care and the use of data-driven diagnostics in modern medicine.

Sector

Healthcare

Industry

Diagnostics & Research

CEO

Mr. Yusheng Han

Employees

667

Headquarters

Guangzhou, China

Website

www.brbiotech.com